About ROPIRIO THERAPEUTICS, INC.
Ropirio Therapeutics is a biotechnology company focused on developing the first lymphatic medicines to improve patients' lives by targeting the lymphatic system, which plays a critical role in serious diseases affecting over 500 million people globally.
Research and development of novel medicines targeting the lymphatic systemIdentification of the first target that activates the lymphatic systemImprovement of lymphatic flow, modulation of inflammation, and prevention of fibrosis
Is this your company?
Claim ROPIRIO THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ROPIRIO THERAPEUTICS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.